ECVT
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 2.64 · operating margin 11%
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Supports a bullish reading. Interesting trend — weekly bias up
ACHAT TOTAL: 24 875 titres (~249 993,75 $ US)
- Insiders
- Humble Patti A.
- Total bought
-
$249,994
Avg buy (VWAP, 90d window) $10.05 vs last close $10.14 (+0.9%)
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-09-10
- Liquidity
- Thin $13,203,306/day · 20d vol
- Last synced
-
2026-09-25 21:10:23
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-10 | Humble Patti A. | Buy | 24,875 | $10.05 | $249,994 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-25
ECVT presents a mixed profile: strong liquidity (85) provides a solid balance sheet buffer, but weak fundamentals (35) driven by negative net income, negative ROE, and declining headcount significantly temper the…
The first sentence of the analysis written for ECVT on 2026-09-25 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 21.8% | 28.6% | 28.6% | 27.4% | 28.9% | |
| Ebit Margin | 8.3% | 6.3% | 18.3% | 16.1% | 8.3% | |
| Ebitda Margin | 19.2% | 19.0% | 30.6% | 25.7% | 21.4% | |
| Operating Profit Margin | 10.8% | 13.9% | 14.0% | 12.7% | 8.9% | |
| Pretax Profit Margin | 3.6% | -0.7% | 11.9% | 11.6% | 2.3% | |
| Continuous Operations Profit Margin | 0.9% | -0.9% | 10.3% | 8.5% | 0.3% | |
| Net Profit Margin | -9.8% | -0.9% | 10.3% | 9.0% | -22.9% | |
| Bottom Line Profit Margin | -9.8% | -0.9% | 10.3% | 9.0% | -22.9% | |
| Current Ratio | 2.644 | 2.638 | 2.066 | 2.069 | 2.010 | |
| Quick Ratio | 2.422 | 2.142 | 1.687 | 1.726 | 1.639 | |
| Solvency Ratio | 0.011 | 0.075 | 0.138 | 0.130 | -0.051 | |
| Cash Ratio | 1.632 | 1.268 | 0.742 | 0.857 | 0.971 | |
| Price To Earnings Ratio | -15.694 | -127.333 | 16.283 | 17.038 | -9.942 | |
| Price To Earnings Growth Ratio | -0.017 | 1.158 | 1.058 | -0.113 | 0.199 | |
| Forward Price To Earnings Growth Ratio | -0.017 | 1.158 | 1.058 | -0.113 | 0.199 | |
| Price To Earnings Diluted Ratio | -15.951 | -127.333 | 16.283 | 17.038 | -10.039 | |
| Price To Earnings Diluted Growth Ratio | -0.017 | 1.158 | 1.058 | -0.113 | 0.199 | |
| Price To Book Ratio | 1.859 | 1.273 | 1.639 | 1.674 | 1.882 | |
| Price To Sales Ratio | 1.550 | 1.266 | 1.673 | 1.443 | 2.281 | |
| Price To Free Cash Flow Ratio | 16.050 | 9.457 | 16.004 | 9.267 | 19.948 | |
| Price To Operating Cash Flow Ratio | 7.995 | 5.949 | 8.405 | 6.343 | 10.734 | |
| Debt To Assets Ratio | 0.342 | 0.499 | 0.490 | 0.485 | 0.480 | |
| Debt To Equity Ratio | 0.714 | 1.284 | 1.276 | 1.292 | 1.251 | |
| Debt To Capital Ratio | 0.416 | 0.562 | 0.561 | 0.564 | 0.556 | |
| Long Term Debt To Capital Ratio | 0.394 | 0.549 | 0.549 | 0.550 | 0.541 | |
| Financial Leverage Ratio | 2.089 | 2.573 | 2.605 | 2.665 | 2.607 | |
| Working Capital Turnover Ratio | 3.737 | 4.466 | 5.212 | 5.758 | 3.274 | |
| Operating Cash Flow Ratio | 1.161 | 1.302 | 1.155 | 1.442 | 0.895 | |
| Operating Cash Flow Sales Ratio | 0.194 | 0.213 | 0.199 | 0.228 | 0.213 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.498 | 0.629 | 0.525 | 0.685 | 0.538 | |
| Debt Service Coverage Ratio | 2.725 | 2.272 | 3.731 | 4.028 | 2.577 | |
| Interest Coverage Ratio | 2.293 | 1.985 | 2.161 | 2.805 | 1.476 | |
| Short Term Operating Cash Flow Coverage Ratio | 14.769 | 17.170 | 15.289 | 20.734 | 14.433 | |
| Operating Cash Flow Coverage Ratio | 0.326 | 0.167 | 0.153 | 0.204 | 0.140 | |
| Capital Expenditure Coverage Ratio | 1.993 | 2.696 | 2.106 | 3.170 | 2.165 | |
| Dividend Paid And Capex Coverage Ratio | 1.993 | 2.696 | 2.106 | 3.170 | 0.262 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | -3.113 | |
| Enterprise Value Multiple | 9.780 | 12.297 | 9.317 | 9.409 | 16.684 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 21.9% | ▼-6.8% | ▼-5.2% |
| Ebit Margin | 8.3% | ▲2.0% | ▼-3.2% |
| Ebitda Margin | 19.1% | ▲0.2% | ▼-4.0% |
| Operating Profit Margin | 10.8% | ▼-3.1% | ▼-1.2% |
| Pretax Profit Margin | 3.6% | ▲4.3% | ▼-2.1% |
| Continuous Operations Profit Margin | 0.9% | ▲1.8% | ▼-2.9% |
| Net Profit Margin | -9.8% | ▼-8.9% | ▼-7.0% |
| Bottom Line Profit Margin | -9.8% | ▼-8.9% | ▼-7.0% |
| Current Ratio | 2.644 | ▲0.006 | ▲0.359 |
| Quick Ratio | 2.422 | ▲0.280 | ▲0.499 |
| Solvency Ratio | 0.011 | ▼-0.064 | ▼-0.049 |
| Cash Ratio | 1.633 | ▲0.364 | ▲0.538 |
| Price To Earnings Ratio | -15.694 | ▲111.640 | ▲8.236 |
| Price To Earnings Growth Ratio | -0.017 | ▼-1.174 | ▼-0.474 |
| Forward Price To Earnings Growth Ratio | -0.017 | ▼-1.174 | ▼-0.474 |
| Price To Earnings Diluted Ratio | -15.951 | ▲111.382 | ▲8.050 |
| Price To Earnings Diluted Growth Ratio | -0.017 | ▼-1.175 | ▼-0.474 |
| Price To Book Ratio | 1.859 | ▲0.586 | ▲0.193 |
| Price To Sales Ratio | 1.550 | ▲0.285 | ▼-0.092 |
| Price To Free Cash Flow Ratio | 16.050 | ▲6.593 | ▲1.905 |
| Price To Operating Cash Flow Ratio | 7.995 | ▲2.046 | ▲0.110 |
| Debt To Assets Ratio | 0.342 | ▼-0.157 | ▼-0.117 |
| Debt To Equity Ratio | 0.714 | ▼-0.570 | ▼-0.450 |
| Debt To Capital Ratio | 0.416 | ▼-0.146 | ▼-0.115 |
| Long Term Debt To Capital Ratio | 0.394 | ▼-0.155 | ▼-0.122 |
| Financial Leverage Ratio | 2.090 | ▼-0.484 | ▼-0.418 |
| Working Capital Turnover Ratio | 3.737 | ▼-0.729 | ▼-0.752 |
| Operating Cash Flow Ratio | 1.161 | ▼-0.141 | ▼-0.030 |
| Operating Cash Flow Sales Ratio | 0.194 | ▼-0.019 | ▼-0.015 |
| Free Cash Flow Operating Cash Flow Ratio | 0.498 | ▼-0.131 | ▼-0.077 |
| Debt Service Coverage Ratio | 2.725 | ▲0.453 | ▼-0.342 |
| Interest Coverage Ratio | 2.293 | ▲0.308 | ▲0.149 |
| Short Term Operating Cash Flow Coverage Ratio | 14.769 | ▼-2.401 | ▼-1.710 |
| Operating Cash Flow Coverage Ratio | 0.326 | ▲0.159 | ▲0.128 |
| Capital Expenditure Coverage Ratio | 1.993 | ▼-0.704 | ▼-0.433 |
| Dividend Paid And Capex Coverage Ratio | 1.993 | ▼-0.704 | ▼-0.053 |
| Dividend Payout Ratio | 0.000 | 0.000 | ▲0.623 |
| Enterprise Value Multiple | 9.780 | ▼-2.517 | ▼-1.718 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.12B | $891.7M | $1.16B | $1.18B | $1.39B | |
| Enterprise value | $1.36B | $1.64B | $1.97B | $1.99B | $2.18B | |
| EV / Sales | 1.87x | 2.33x | 2.85x | 2.42x | 3.57x | |
| EV / Op. cash flow | 9.66x | 10.97x | 14.30x | 10.64x | 16.78x | |
| EV / Free cash flow | 19.39x | 17.44x | 27.24x | 15.55x | 31.19x | |
| EV / EBITDA | 9.78x | 12.30x | 9.32x | 9.41x | 16.68x | |
| Net debt / EBITDA | 1.69x | 5.63x | 3.84x | 3.80x | 6.01x | |
| Current ratio | 2.64x | 2.64x | 2.07x | 2.07x | 2.01x | |
| Income quality | 22.31x | 3.29x | 1.93x | 2.67x | -0.93x | |
| Graham number | — | — | $9 | $8 | — | |
| Graham net-net | -$3 | -$7 | -$8 | -$7 | -$7 | |
| Tax burden | -275.8% | 132.5% | 86.8% | 77.8% | -1003.9% | |
| Interest burden | 43.0% | -11.3% | 64.7% | 71.8% | 27.4% | |
| Working capital | $198.6M | $188.6M | $126.9M | $138.3M | $146.6M | |
| Invested capital | $1.10B | $1.29B | $1.25B | $1.28B | $1.32B | |
| Return on assets | -5.6% | -0.4% | 3.9% | 3.9% | -7.2% | |
| Operating ROA | 5.1% | 5.4% | 5.2% | 5.5% | 2.1% | |
| Return on tangible assets | -8.1% | -0.5% | 5.4% | 5.5% | -10.1% | |
| Return on equity | -11.8% | -0.9% | 10.1% | 10.4% | -18.9% | |
| Return on invested capital | 1.7% | 5.7% | 4.8% | 4.3% | 0.4% | |
| Return on capital employed | 6.9% | 5.8% | 5.6% | 5.9% | 3.1% | |
| Earnings yield | -6.3% | -0.7% | 6.2% | 6.2% | -10.0% | |
| Free cash flow yield | 6.2% | 10.6% | 6.2% | 10.8% | 5.0% | |
| Capex / Op. cash flow | 50.2% | 37.1% | 47.5% | 31.5% | 46.2% | |
| Capex / Depreciation | 89.6% | 78.8% | 77.2% | 74.4% | 75.2% | |
| Capex / Sales | 9.7% | 7.9% | 9.5% | 7.2% | 9.8% | |
| SG&A / Sales | 9.1% | 11.9% | 11.5% | 10.4% | 16.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.3% | 1.6% | 2.3% | 2.5% | 5.2% | |
| Intangibles / Total assets | 30.6% | 27.9% | 28.4% | 28.3% | 28.6% | |
| Days sales outstanding | 43d | 40d | 43d | 33d | 52d | |
| Days payables outstanding | 31d | 32d | 30d | 25d | 44d | |
| Operating cycle | 60d | 82d | 76d | 60d | 97d | |
| Cash conversion cycle | 29d | 50d | 47d | 36d | 54d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-09 Ecovyst Inc. (NYSE:ECVT) Receives $14.50 Consensus Target Price from Analysts Shares of Ecovyst Inc. (NYSE: ECVT - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, four have issued a buy recommendation and one has
- 2026-09-04 Public Company Director and Former Fortune 50 Chief Accounting Officer Patti Humble Joins the Exceptional Women Alliance (EWA) /PRNewswire/ -- The Exceptional Women Alliance (EWA) proudly announces the addition of Patti Humble, independent public company board director and former Chief
- 2026-09-02 Pick These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios PARR, AMKR, KSS, AVT and ECVT stand out with attractive EV-to-EBITDA ratios and strong earnings outlook.
- 2026-08-24 Ecovyst Announces Chief Financial Officer Transition WAYNE, Pa., Aug. 24, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today announced that the Board of Directors of the Company has appointed Laurie Bergman as Chief Financial Officer effective August 24, 2026. Ms. Bergman replaces Michael Feehan, who will be departing the Company.
- 2026-08-19 Ecovyst: Portfolio Recycling Creates A Higher-Quality Sulfur Platform Ecovyst transformed its portfolio by divesting Advanced Materials & Catalysts at 9.8x EBITDA and acquiring Calabrian at 8x EBITDA, enhancing its sulfur platform. ECVT''s Q2 2026 saw sales rise 42% and adjusted EBITDA up 26.7%, driven by volume growth, pass-through pricing, and strategic asset integration. Recurring revenues, regional logistics barriers, and long-term contracts position ECVT as critical process infrastructure, not a commodity chemical producer.
- 2026-08-14 Ecovyst Inc (ECVT) Shares Surge 3.1% -- What GF Score of 81 Tells Investors On August 14, 2026, Ecovyst Inc (ECVT) shares rose 3.1% to $10.39, reflecting a notable uptick amid a broader market context. The stock has fluctuated between a
- 2026-08-08 Ecovyst Q2 Earnings Call Highlights Ecovyst NYSE: ECVT reported second-quarter 2026 sales of $250 million and adjusted EBITDA of $53 million, with the company citing higher sulfuric acid volumes, favorable net pricing and elevated refinery utilization. Adjusted EBITDA increased 27% from the second quarter of 2025 and fell within the company''s guidance range.
- 2026-08-05 Ecovyst Inc. (ECVT) Q2 2026 Earnings Call Transcript Ecovyst Inc. (ECVT) Q2 2026 Earnings Call Transcript
- 2026-08-05 Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook WAYNE, Pa., Aug. 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today reported results for the second quarter ended June 30, 2026. On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which includes the Company''s investment in affiliated companies, Zeolyst International and Zeolyst C.V.
- 2026-07-28 Ecovyst Inc. $ECVT Shares Purchased by Arrowstreet Capital Limited Partnership Arrowstreet Capital Limited Partnership grew its holdings in shares of Ecovyst Inc. (NYSE: ECVT) by 246.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,829,034 shares of the company''s stock after purchasing an additional 3,435,942 shares during the